Jump to the Navigation Menu
Login to My AlzForum
Jump to the Search form

Papers

256156 Results

Sort By:

Publication Date
Journal Title
First Author
Most Commented

Go to another page:

1
2
3
... 17078

Send results to Selected: 0 Clear selection

Cudkowicz, Rosas, Hayden. Riluzole therapy in patients with Huntington's disease. Neurology. 50 (Suppl. 4): 72, Apr 1998

Travers J, Milgram S. An Experimental Study of the Small World Problem. Sociometry Vol. 32, No. 4 (Dec., 1969)

Included in: News

Cserr HF. Flow of Brain Interstitial Fluid and Drainage into Cerebrospinal Fluid and Lymph. In: Ishii S., Nagai H., Brock M. (eds) Intracranial Pressure V. Springer, Berlin, Heidelberg. (1983)

Paloneva J, Autti T, Hakola P, Haltia MJ. Polycystic Lipomembranous Osteodysplasia with Sclerosing Leukoencephalopathy (PLOSL). In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Mefford HC, Stephens K, Amemiya A, Ledbetter N, editors. SourceGeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2017. 2002 Jan 24 [updated 2015 Mar 12].

Benzinger TL, Gordon BA, Friedrichsen KA, Su Y, Christensen J, Hornbeck RC, Mishra S, Aldea P, Cash L, Ances B, McConathy J, Koeppe RA, McDade E, Cairns NJ, Morris JC, Bateman R, Buckles V, the Dominantly Inherited Alzheimer Network (DIAN) Study Group. Tau PET Imaging With Av-1451 in Autosomal Dominant Alzheimer's Disease: Update from the Dominantly Inherited Alzheimer Network (DIAN). Alzheimer's & Dementia, July 2016

Fullerton T, Binneman B, David W, Delnomdedieu M, Kupjec J, Lockwood P, Mancuso J, Miceli J, Bell J. A Phase 2 Clinical Trial of Pf-05212377 (Sam-760) in Subjects With Mild to Moderate Alzheimer's Disease With Existing Neuropsychiatric Symptoms on a Stable Daily Dose of Donepezil. Alzheimer's & Dementia: The Journal of the Alzheimer's Association, Volume 12, Issue 7,

Qiu R, Liu R, Wills AM, He P, Leurent C, Hajos-Korcsok E, Mendes da Costa L, Alexander RC. PF-06648671–A Novel Gamma Secretase Modulator: Safety, Tolerability, Pharmacokinetics, and Effects on Plasma Amyloid-B Levels Following Single Oral Ascending Doses in Healthy Volunteers. July 2016, Volume 12, Issue 7, Supplement

de Wilde A, van der Flier WM, Bouwman FH, Ossenkoppele R, Pelkmans W, Groot C, Zwan MD, Yaqub MM, Newman V, Lammertsma AA, van Berckel BN, Scheltens P. The Diagnostic Value of Amyloid Pet in an Unselected Cohort of Memory Clinic Patients. Alzheimer's & Dementia, July 2016, Volume 12, Issue 7, Supplement

Included in: News

Zenaro E, Constantin G. Targeting neuaikroinflammation in the treatment and prevention of Alzheimer’s disease. Drugs of the Future 2017, 42(1): 21-42.

Leshner AI, Landis S, Stroud C, Downey A, Committee on Preventing Dementia and Cognitive Impairment; Board on Health Sciences Policy; Health and Medicine Division; National Academies of Sciences, Engineering, and Medicine. Preventing Cognitive Decline and Dementia: A Way Forward. Washington (DC): National Academies Press (US); 2017 Jun. The National Academies Collection: Reports funded by National Institutes of Health.

Included in: News

Landen J. Safety, tolerability, pharmacokinetics and pharmacodynamics of monthly and quarterly doses of ponezumab (PF-04360365) in subjects with mild-to-moderate Alzheimer's disease. Alzheimer's & Dementia 8.4 (2012): P708.

Lasser R. Efficacy and safety of gantenerumab in prodromal Alzheimer’s disease: Results from scarlet road—a global, multicenter trial. Alzheimer's & Dementia: The Journal of the Alzheimer's Association 11.7 (2015): P331-P332.

Blaettler T. Clinical trial design of CREAD: a randomized, double-blind, placebo-controlled, parallel-group Phase-3 study to evaluate crenezumab treatment in patients with prodromal-to-mild Alzheimer’s disease. Alzheimer's & Dementia: The Journal of the Alzheimer's Association 12.7 (2016): P609.

Institute of Medicine (US) Committee on Assessing the Need for Clinical Trials of Testosterone Replacement Therapy, Liverman CT, Blazer DG. Testosterone and Aging: Clinical Research Directions. Washington (DC): National Academies Press (US); 2004.

Included in: News

Khan K. Heading for trouble: is dementia a game changer for football?. BJSM Blog, 15 Feb 2017

Go to another page:

1
2
3
... 17078

Current Filters

Remove all filters

Filter By

Papers of the Week

Current Week (243)
12-18 Apr 2024 (288)
5-11 Apr 2024 (270)
29 Mar - 4 Apr 2024 (264)

Type ?

Milestone (286)
Alzforum Recommends (3833)

Publication Range

From
1. Month
2. Year
To
1. Month
2. Year

Background
Methods
FAQ

Enter your keywords

LOGIN
HOME
About Us
Newsletter

NEWS
- All News
- Conference Coverage
WEBINARS
- All Webinars
Databases
- AlzAntibodies
- AlzBiomarker
- AlzPedia
- AlzRisk
- Brain Banks
- Genetics
  - AlzGene
  - HEX
  - Mutations
- Protocols
- Research Models
- Therapeutics
PAPERS
PROFESSIONAL RESOURCES
ABOUT AD
MY ALZFORUM

Back to the Top

Terms of Service
How to Cite
Privacy Policy
Site Map
Contact Us